These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7169965)

  • 1. Pharmacokinetic and pharmacological features of oestradiol valerate.
    Düsterberg B; Nishino Y
    Maturitas; 1982 Dec; 4(4):315-24. PubMed ID: 7169965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and biotransformation of estradiol valerate in ovariectomized women.
    Düsterberg B; Schmidt-Gollwitzer M; Hümpel M
    Horm Res; 1985; 21(3):145-54. PubMed ID: 2987096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the pharmacokinetic properties of three estradiol esters.
    Oriowo MA; Landgren BM; Stenström B; Diczfalusy E
    Contraception; 1980 Apr; 21(4):415-24. PubMed ID: 7389356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial and vaginal response to three different oestrogen preparations administered by the transdermal and oral routes.
    Johannisson E; Landgren BM; Diczfalusy E
    Maturitas; 1988 Oct; 10(3):181-92. PubMed ID: 3185292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High fecundity rates in donor oocyte recipients and in-vitro fertilization surrogates using parenteral oestradiol valerate.
    Feinman M; Sher G; Massaranni G; Vaught L; Andreyko J; Salem R; Zouves C; Dodge S
    Hum Reprod; 1993 Jul; 8(7):1145-7. PubMed ID: 8408502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum lipids during treatment with norgestrel, oestradiol-valerate and cycloprogynon.
    Nielsen FH; Honoré E; Kristoffersen K; Secher NJ; Pedersen GT
    Acta Obstet Gynecol Scand; 1977; 56(4):367-70. PubMed ID: 602705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interpretation of toxicity tests in rats treated with oestradiol valerate in the diet.
    Kuhnz W; Putz B
    Pharmacol Toxicol; 1989 Sep; 65(3):217-22. PubMed ID: 2813295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers.
    Schug BS; Donath F; Blume HH
    Int J Clin Pharmacol Ther; 2012 Feb; 50(2):100-17. PubMed ID: 22257576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oestriol, oestradiol valerate and ethinyloestradiol on serum proteins in oestrogen-deficient women.
    Bergink EW; Crona N; Dahlgren E; Samsioe G
    Maturitas; 1981 Dec; 3(3-4):241-7. PubMed ID: 7199609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post natal oestrogen administration stimulates precocious endometrial gland development in the horse.
    Wilsher S; Lefranc AC; Allen WR
    Equine Vet J; 2009 Sep; 41(7):678-84. PubMed ID: 19927587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of serum oestrogen concentrations in post-menopausal women taking oestrone sulphate and oestradiol.
    Anderson AB; Sklovsky E; Sayers L; Steele PA; Turnbull AC
    Br Med J; 1978 Jan; 1(6106):140-2. PubMed ID: 620226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reappraisal of the feedback effects of oestradiol upon luteinizing hormone surge.
    Levran D; Ben-Shlomo I; Luski A; Ben-Rafael Z; Dor J; Mashiach S; Seidman DS
    Hum Reprod; 1995 Dec; 10(12):3117-20. PubMed ID: 8822425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women.
    Aedo AR; Landgren BM; Diczfalusy E
    Maturitas; 1990 Nov; 12(4):333-43. PubMed ID: 2124648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
    Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
    Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of climacteric complaints with Org OD 14: a comparative study with oestradiol valerate and placebo.
    Crona N; Samsioe G; Lindberg UB; Silfverstolpe G
    Maturitas; 1988 Mar; 9(4):303-8. PubMed ID: 3288845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
    Mc Manus J; Mc Eneny J; Thompson W; Young IS
    Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a massive single oral dose of oestradiol valerate in a young woman.
    Punnonen R; Salmi T
    Ann Clin Res; 1983 Jun; 15(3):134-6. PubMed ID: 6638929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of steroids on endometrial oxytocin mRNA production.
    Behrendt-Adam CY; Adams MH; Simpson KS; McDowell KJ
    J Reprod Fertil Suppl; 2000; (56):297-304. PubMed ID: 20681141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum oestrone, oestradiol and oestriol levels in ovariectomized women receiving a high dose of oestradiol valerate.
    Heinonen PK; Saarikoski S; Pyykkö K; Pystynen P
    Maturitas; 1982 Dec; 4(4):273-6. PubMed ID: 7169962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol valerate/dienogest.
    Wellington K; Perry CM
    Drugs; 2002; 62(3):491-504; discussion 505-6. PubMed ID: 11827562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.